Our 2025 Annual Conference convened more than 250 key stakeholders around the theme “Driving Change: Putting Employers Behind the Wheel.” With over 180 million Americans receiving healthcare coverage through employer-sponsored plans, the employer’s role in shaping the future of healthcare delivery has never been more critical.

The event served as a strategic guide through today’s complex landscape—spanning legislative developments, high-cost claims and emerging therapies, and employee engagement. Several core themes emerged to empower employers as catalysts for change: leveraging data to target priorities and foster accountability, and cultivating ongoing collaboration to refine strategies in response to evolving trends. If you were not able to make the event, here’s a recap video featuring a few highlights and comments from the audience! Thank you to all of our speakers, sponsors, and attendees for making this event possible!

Special thanks to our partnering organization, American Journal of Managed Care (AJMC), for attending this year's conference and publishing articles on several of our sessions. These article include:

• Payers and Providers Seek Common Ground on Costs, Technology, and Value-Based Care | Rising costs, strained provider networks, and outdated administrative processes continue to destabilize the US health care system, leaving both patients and employers grappling with uncertainty. At the Greater Philadelphia Business Coalition on Health (GPBCH) annual conference, a session titled “Merge Ahead: The Health System and Payer Dynamic” brought together leaders from both the provider and payer sides to examine the financial, technological, and operational changes needed to sustain care delivery. Read the full article here
  
  
• Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia | As employers weigh the growing role of glucagon-like peptide-1 (GLP-1) therapies in benefit design, 2 US cities, Philadelphia and Wilmington, are demonstrating how accountability, communication, and data-driven strategies can shape sustainable programs. Read the full article here
  
  
• GPBCH Session Spotlights Barriers and Solutions in GLP-1 Affordability | Prescription drug costs in the US remain among the highest in the world, and despite breakthrough therapies that transform care for chronic and complex conditions, affordability continues to lag behind innovation. Patients, employers, and health plans alike are grappling with the strain of rising drug expenditures, compounded by aggressive pharmaceutical marketing and the complexity of the current pharmacy benefit structure. Read the full article here